Omicron COVID-19 Vaccine (Vero Cell), Inactivated

BIOLOGICAL2 trials

Sponsors

China National Biotec Group Company Limited

Conditions

COVID-19

Phase 1

A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and Above

China National Biotec Group Company LimitedCOVID-19

Start: 2022-05-01End: 2023-10-01Updated: 2023-06-18

Phase 3

Study on Sequential Immunization of Omicron Inactivated COVID-19 Vaccine and Prototype Inactivated COVID-19 Vaccine in Population Aged 18 Years Old and Above

China National Biotec Group Company LimitedCOVID-19

Start: 2022-05-10End: 2023-11-10Updated: 2023-06-18